0001193805-15-001993.txt : 20151204
0001193805-15-001993.hdr.sgml : 20151204
20151204160543
ACCESSION NUMBER: 0001193805-15-001993
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151202
FILED AS OF DATE: 20151204
DATE AS OF CHANGE: 20151204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001368514
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 562590442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
BUSINESS PHONE: (201) 478-5552
MAIL ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
FORMER COMPANY:
FORMER CONFORMED NAME: R&R ACQUISITION VI, INC
DATE OF NAME CHANGE: 20060707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Jerrold B
CENTRAL INDEX KEY: 0001542519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36728
FILM NUMBER: 151270149
MAIL ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
4
1
e614333_4-jgrossman.xml
OWNERSHIP DOCUMENT
X0306
4
2015-12-02
0
0001368514
ADMA BIOLOGICS, INC.
ADMA
0001542519
Grossman Jerrold B
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
1
0
0
0
Common Stock, $0.0001 par value per share
2015-12-02
4
P
0
6000
9.1601
A
56058
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.145 to $9.20 per share. The reporting person undertakes to provide to ADMA Biologics, Inc., any security holder of ADMA Biologics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on December 2, 2015.
38,294 of these shares are held by the Genesis Foundation, an entity for which Jerrold Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc.
On October 21, 2015, the reporting person resigned as the managing member of Maggro, LLC. Therefore, as of October 21, 2015 the reporting person is no longer the beneficial owner of 528,016 shares of the Issuer's Common Stock held by Maggro, LLC. The reporting person disclaims beneficial ownership of the Issuer's Common Stock held by Maggro, LLC, except to the extent of his nominal pecuniary interest therein.
/s/ Jerrold B. Grossman
2015-12-04